Who Owns Editas Medicine Stock?
NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 91.13%
- Held by insiders
- 0.20%
- Institutional holders
- 288
- Institutions 91.1%
- Insiders 0.2%
- Public and other 8.7%
Who owns Editas Medicine stock?
Institutional investors own about 91.1% of Editas Medicine's shares, spread across 288 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.20% of EDIT.
The largest institutional holders are Blackrock Inc. (9.33%), TCG Crossover Management, LLC (7.20%) and Commodore Capital Lp (5.76%). Together, the top 10 institutions control 52.8% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their EDIT positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of EDIT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 14.40M | 9.33% | +36.0% |
| TCG Crossover Management, LLC | 11.11M | 7.20% | 0.0% |
| Commodore Capital Lp | 8.89M | 5.76% | 0.0% |
| RA Capital Management, L.P. | 8.89M | 5.76% | 0.0% |
| Adar1 Capital Management, LLC | 8.89M | 5.76% | 0.0% |
| Paradigm Biocapital Advisors LP | 7.58M | 4.91% | +35.6% |
| State Street Corporation | 7.04M | 4.56% | +221.1% |
| Vanguard Capital Management LLC | 6.07M | 3.94% | -1.1% |
| Vanguard Portfolio Management LLC | 4.68M | 3.03% | +30.1% |
| Geode Capital Management, LLC | 3.89M | 2.52% | +51.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of EDIT
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.89M | 3.17% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 4.23M | 2.74% |
| iShares Trust-iShares Russell 2000 ETF | 3.98M | 2.58% |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund | 2.03M | 1.32% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.31M | 0.85% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.15M | 0.74% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.10M | 0.71% |
| iShares Trust-iShares Biotechnology ETF | 1.08M | 0.70% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 636.28K | 0.41% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 574.59K | 0.37% |
Frequently asked questions
Who is the largest shareholder of Editas Medicine?
Blackrock Inc. is the largest institutional shareholder of EDIT, owning 9.33% of shares outstanding (14.40M shares) as of its latest 13F filing.
What percentage of Editas Medicine is owned by institutions?
Institutions own about 91.1% of EDIT shares and 91.3% of the public float.
How much of Editas Medicine do insiders own?
Insiders, such as officers and directors, own about 0.20% of EDIT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.